Literature DB >> 28287300

Clinical and molecular epidemiology of Acinetobacter baumannii bloodstream infections in an endemic setting.

Dror Marchaim1,2, Dana Levit2, Roy Zigron2, Michal Gordon3, Tsillia Lazarovitch4, Joao A Carrico5, Vered Chalifa-Caspi3, Jacob Moran-Gilad6,7,8.   

Abstract

AIM: The transmission dynamics of Acinetobacter baumannii in endemic settings, and the relation between microbial properties and patients' clinical outcomes, are yet obscure and hampered by insufficient metadata. METHODS &
RESULTS: Of 20 consecutive patients with A. baumannii bloodstream infection that were thoroughly analyzed at a single center, at least one transmission opportunity was evident for 85% of patients. This implies that patient-to-patient transmission is the major mode of A. baumannii acquisitions in health facilities. Moreover, all patients who died immediately (<24 h of admission) were infected with a single clone (ST457; relative risk = 1.6; p = 0.05).
CONCLUSION: This preliminary analysis should prompt further investigation by mapping genomic virulence determinants among A. baumannii ST457 lineage compared with other strains.

Entities:  

Keywords:  Gram-negative; MDR; MLST; carbapenem; nonfermenter; nosocomial infections; typing

Mesh:

Substances:

Year:  2017        PMID: 28287300     DOI: 10.2217/fmb-2016-0158

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  6 in total

1.  Risk factors and clinical outcomes for intensive care unit patients with mul-tidrug-resistant Acinetobacter spp. bacteremia.

Authors:  Malbaša Đekić; T Dugandžija; G Dragovac; D Medić; M Paut Kusturica
Journal:  Hippokratia       Date:  2020 Jan-Mar       Impact factor: 0.471

2.  Neonatal Vitamin A Supplementation and Vitamin A Status Are Associated with Gut Microbiome Composition in Bangladeshi Infants in Early Infancy and at 2 Years of Age.

Authors:  M Nazmul Huda; Shaikh M Ahmad; Karen M Kalanetra; Diana H Taft; Md J Alam; Afsana Khanam; Rubhana Raqib; Mark A Underwood; David A Mills; Charles B Stephensen
Journal:  J Nutr       Date:  2019-06-01       Impact factor: 4.798

Review 3.  Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (vs monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex.

Authors:  Stamatis Karakonstantis; Evangelos I Kritsotakis
Journal:  Infection       Date:  2021-07-14       Impact factor: 3.553

4.  Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital.

Authors:  Hua Zhou; Yake Yao; Bingquan Zhu; Danhong Ren; Qing Yang; Yiqi Fu; Yunsong Yu; Jianying Zhou
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

5.  The effect of the efflux pump inhibitor Carbonyl Cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii.

Authors:  Alejandra Sanchez-Carbonel; Belén Mondragón; Nicolás López-Chegne; Isaac Peña-Tuesta; Gladys Huayan-Dávila; Dora Blitchtein; Hugo Carrillo-Ng; Wilmer Silva-Caso; Miguel Angel Aguilar-Luis; Juana Del Valle-Mendoza
Journal:  PLoS One       Date:  2021-12-17       Impact factor: 3.240

6.  Characterization of carbapenem-resistant hypervirulent Acinetobacter baumannii strains isolated from hospitalized patients in the mid-south region of China.

Authors:  Jun Li; Ting Yu; Yi Luo; Jing-Yi Peng; Yu-Jia Li; Xiao-Yan Tao; Yong-Mei Hu; Hai-Chen Wang; Ming-Xiang Zou
Journal:  BMC Microbiol       Date:  2020-09-14       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.